Associated with the middle T antigen of polyomavirus is a novel phosphatidylinositol (Ptdlns) kinase activity which phosphorylates Ptdlns at the D-3 position of the inositol ring. We have undertaken an analysis of myo-[3H]inositol-containing compounds in a panel of NIH 3T3 cell lines stably transfected with transforming and nontransforming middle T antigen mutants. All cell lines from which PtdIns 3-kinase activity coprecipitated with middle T antigen exhibited modestly elevated levels of Ptdlns(3)P and compounds with predicted PtdIns(3,4)P2 and Ptdlns(3,4,5)P3 structures. Complex formation between middle T antigen and Ptdlns 3-kinase correlated not with an increase in total inositol phosphate levels but rather with elevated levels of InsP2 and InsP4. A specific increase in the level of an InsP2 species which comigrated in high-pressure liquid chromatography analysis with Ins(3,4)P2 was observed. These results suggest that association of the polyomavirus middle T antigen with Ptdlns 3-kinase activates a distinct inositol metabolic pathway.
Activation of phosphatidylinositol (Ptdlns) turnover is a hallmark feature of many receptor-mediated signal transduction and cellular growth regulation pathways. A variety of growth factor receptors respond to agonist binding by stimulation of phosphoinositidase C activity, generating at least two molecules with second-message function: inosito/ (1,4,5)triphosphate [Ins(1,4,5)P3] and diacylglycerol (reviewed in reference 2 and 28) . Further interest in the role of phosphoinositide signaling has been generated by the recent finding of PtdIns 3-kinase activity associated with retroviral oncogene protein-tyrosine kinases, including v-src, v-abl, v-ros, and v-erbB (12, 14, 15, 22, 27, 40, 41) , and receptor protein-tyrosine kinases, including the platelet-derived growth factor (PDGF) receptor (20) , the colony-stimulating factor 1 receptor (44) , and the insulin receptor (11, 33) . This PtdIns 3-kinase activity, however, phosphorylates PtdIns at the D-3 position of the inositol ring to form phosphatidylinositol(3)phosphate [Ptdlns(3)P] rather than the D-4 position seen in the phospholipase C-dependent signal transduction pathway (39, 45) . This novel type 1 Ptdlns 3-kinase (46) has been recently demonstrated also to phosphorylate phosphatidylinositol(4)phosphate [Ptdlns(4)P] and phosphatidylinositol (4, 5) bisphosphate [PtdIns(4,5)P2] to form products with predicted phosphatidylinositol (3, 4) bisphosphate [Ptdlns (3, 4) P2] and phosphatidylinositol (3, 4, 5) triphosphate [PtdIns (3, 4, 5) P3] structures, respectively (1) . Although no correlation between stimulation of Ptdlns 3-kinase activity and Ptdlns signaling pathways has been established, the association of PtdIns 3-kinase activity with oncogene products suggests that it plays an important role in growth control.
Among the first oncogene products shown to have associated Ptdlns 3-kinase activity was the middle T antigen of polyomavirus (47) . Middle T antigen, which is both sufficient and necessary for transformation of established cell cultures (36) , forms a stable complex with an activated form of cellular tyrosine kinase, pp6O-src (3, 9) , and also with the related kinases pp62c-Yes (23) and p59&fy (4, 24) . Associated with these middle T antigen-tyrosine kinase complexes is an 81-kilodalton phosphoprotein (6, 15; S.A.C., unpublished data) whose presence correlates with PtdIns 3-kinase activity and which is most likely identical to the putative 85-kilodalton Ptdlns 3-kinase which binds the PDGF receptor (20) . Ptdlns 3-kinase activity and p81 are associated in immune precipitates containing all transforming and certain nontransforming middle T antigen mutants (e.g., d11015) but not with other nontransforming middle T antigen mutants which retain the ability to bind pp6-src (6, 30) . Association of PtdIns 3-kinase activity with middle T antigen, therefore, appears necessary but not sufficient for cell transformation.
Although physical association between Ptdlns 3-kinase activity and middle T antigen-tyrosine kinase complexes has been demonstrated in immune complex kinase assays, it remains unclear whether this association affects Ptdlns metabolism in vivo. Dephosphorylation of p81 either in vitro or during extraction correlates with loss of Ptdlns 3-kinase activity, suggesting that phosphorylation of p81 by pp6Oc-src could then stimulate production of PtdIns(3)P (7). The PtdIns(3)P product, however, does not fit into any of the described pathways for inositol turnover, and conflicting reports about activation of inositol turnover in middle T antigen and v-src-transformed cells have appeared in the literature. We have therefore undertaken an analysis of inositol metabolites in middle T antigen-transformed cells to define whether the levels of Ptdlns 3-kinase products or other inositol-containing compounds are altered as a consequence of middle T antigen expression.
MATERIALS AND METHODS Cell cultures. NIH 3T3 cells which were cloned for G418 sensitivity and high efficiency of transformation provided the basis for the cell lines presented in this communication. Cells were cotransfected with cloned middle T antigen DNA and the gene for neomycin resistance (Neor) and selected for G418 resistance as described previously (6 (15 ,000 x g, 10 min). The inositol phosphate-containing supernatants were neutralized with 0.12 ml of EDTA (10 mM) and 0.5 ml of tri-N-octylamineFreon (1:1) (10) and stored at -20°C. The inositol lipidcontaining perchloric acid pellets were washed once with perchloric acid (0.5 ml) and once with EDTA (100 mM) at 4°C, and the final pellet was subjected to methylamine deacylation (18) . The pellets were suspended in 50 ml of H20 to which was added 1.0 ml of methanol-40% methylaminen-butanol (4:4:1). After 45 min at 56°C, the samples were dried in a Speed Vac concentrator (Savant). The dried glycerophosphoinositide (GroPIns) products were suspended in H20, clarified by centrifugation, and extracted twice with butanol-petroleum ether-ethyl formate (20:4:1). The preparations were then dried and stored at -20°C.
HPLC separation of GroPIns. Deacylated extracts of the inositol-containing lipids were analyzed by strong anionexchange high-pressure liquid chromatography (HPLC) with a Whatman Partisphere 5-SAX column as described by Stephens et al. (39) . The HPLC apparatus consisted of a 1.0-ml injection loop, a digitally controlled mixing device, and two independent pumps [A, which pumped H20, and B, which drew 1.25 M (NH4)2HP04 [ [31] ), and phosphotyrosine-specific antibodies were purified as already described (32) . Ptdlns kinase assays were performed as described above, and after chromatography, PtdInsP, PtdInsP2, and the predicted PtdInsP3 were identified by autoradiography, scraped from the plates, and directly subjected to methylamine deacylation. When (6, 8, 20, 30) . It has been recently reported by Auger et al. (1) that PtdIns 3-kinase activity associated with the PDGF receptor was capable of utilizing Ptdlns(4)P and PtdIns(4,5)P2 as substrates. To test whether the middle T antigen associated PtdIns 3-kinase also recognized these substrates, lysates from cells harboring prototypes of middle T antigen mutant classes were precipitated by using middle T antibodies and immune complex kinase assays were performed by using a mixture of PtdIns, PtdInsP, and PtdInsP2 as a substrate. PtdIns 3-kinase activity associated with wild-type and d18 middle T antigen utilized all three substrates with roughly equal efficiencies to produce products with predicted PtdInsP, PtdInsP2, and PtdInsP3 structures (Fig. 1) Fig. 2 . 32P04-labeled standards in this experiment, corresponding to the deacylation products of PtdIns(3)P and the putative PtdIns(3,4)P2 and PtdIns (3,4,5)P3 compounds, were generated in vitro by using anti-phosphotyrosine immune complexes prepared from quiescent NIH 3T3 cells treated with PDGF. As described previously, Ptdlns(3)P represents approximately 0.2% of the total inositol-containing lipid and its deacylation product eluted immediately before GroPIns(4)P on strong anionexchange HPLC (peak at fraction 32). The putative PtdIns(3,4)P2 product represents approximately 0.01% of the total inositol-containing lipid fraction in these cells, and its deacylation product eluted immediately before GroPIns (1,4)P2 in this HPLC system (peak at fractions 85 and 86 in Fig. 2B ). Finally, the putative PtdIns(3,4,5)P2 product represents approximately 0.02% of the total inositol-containing lipid in these cells and its deacylation product (peak at fraction 140 in Fig. 2C Table 2 . When normalized to the level of PtdIns, the PtdIns(3)P content was modestly but consistently (P < 0.05) elevated (15 to 25%) in cell lines expressing d11015, d18, or wild-type middle T antigen relative to the level in cells expressing Neor alone. By contrast, the levels of PtdIns(4)P were reduced in the cell lines which express middle T antigen with associated Ptdlns 3-kinase activity. PtdInsP2 levels were reduced in all cell lines expressing middle T antigen, and no correlation could be established between either cell transformation or the presence of Ptdlns 3-kinase activity in vitro and PtdInsP2 levels. From these results, we conclude that middle T antigen which has associated Ptdlns 3-kinase activity in vitro also activates PtdIns 3-kinase in vivo. The levels of Ptdlns(3)P in polyomavirus-transformed cells, while low, could not be further stimulated by addition of PDGF, and they approximated the levels seen after PDGF stimulation of quiescent normal fibroblasts (E.T.U., unpublished data). (1) . To define whether polyomavirus-transformed cells also exhibit levels of these novel products, we compared the HPLC elution patterns of 32P-labeled GroPInsP2 and GroPInsP3 standards generated in vitro with those of deacylated lipid preparations derived from middle T-expressing cells (as in Fig. 2B and C) . Because of the exceedingly low levels of these compounds in normal fibroblasts (0.005 to 0.01% of the radioactivity associated with PtdIns), duplicate or triplicate samples of deacylated 3H-labeled lipid preparations were pooled to yield enough of a sample to permit detection of these compounds. The levels of these products were elevated two-to threefold in transformed cells (Table 3) . Furthermore, at least PtdInsP3 levels appeared to correlate with the presence of PtdIns 3-kinase activity in cells expressing middle T antigen mutants. While the very low levels of these compounds precluded the derivation of statistically significant values, we tentatively conclude that a correlation appears to exist between the accumulation of these novel products in vivo and the detection of middle T-associated PtdIns 3-kinase activity in vitro.
Inositol phosphate levels in middle T antigen-transformed cells. The very low levels of the Ptdlns 3-kinase products in cells with active Ptdlns 3-kinase may reflect rapid processing of these products to other compounds. We therefore also screened our panel of middle T antigen mutants for changes in the levels of soluble inositol phosphates. Perchloric acidsoluble inositol phosphates were neutralized with tri-Noctylamine and subjected to strong anion-exchange HPLC using a Partisil 10 initial studies also revealed that the total levels of InsP3 were statistically invariant among cell lines expressing transforming and nontransforming middle T antigen mutants. We conclude that gross changes in the levels of inositol phosphates do not correlate with the presence of activated Ptdlns 3-kinase or cell transformation.
A correlation was established between the overall levels of InsP4 in cell lines which express activated PtdIns 3-kinase. Cells expressing wild-type, d18, or d11015 middle T antigen exhibited a twofold increase in the level of InsP4 compared with cell lines which express either d123 or NG59 middle T antigen. Because of restrictions imposed by the HPLC method used, however, we were unable to define whether this represents accumulation of a particular InsP4 isomer.
InsP2 levels were also elevated in cells with activated Ptdlns 3-kinase. Significantly elevated levels of InsP2 were detected in wild type-, d18-, and d11015-transfected cell lines relative to cell lines expressing d123, NG59, or Neor. We optimized the separation of InsP2 isomers by using isocratic ammonium formate-phosphate elution. Illustrated in Fig. 3 are the elution positions of Ins(1,2)P2, Ins(1,3)P2, Ins(1,4)P2, Ins(3,4)P2, and Ins(4,5)P2 standards (panel A) in comparison with the 3H-labeled inositol phosphates present in d123 (panel B) and d11015 extracts (panel C). The increase in radioactivity recovered in InsP2 in d11015-transformed cells could be largely accounted for by the increase in radioactivity comigrating with the Ins(3,4)P2 and Ins(1,2)P2 standards. When this analysis was extended to include the other cell lines expressing middle T mutants, the level of radioactivity which comigrated with the Ins(1,2)P2 standard was found to be elevated approximately twofold in all of the cell lines expressing middle T antigen which is capable of binding to pp6c-src (Table 5) . By contrast, an approximately twofold increase in the Ins(3,4)P2 fraction was consistently and significantly observed only in cell lines with activated Ptdlns 3-kinase activity. The levels of Ins(1,4)P2 were invariant among the cell lines analyzed, with the exception of d18, which exhibited reduced levels of this compound.
The finding of elevated levels of a compound comigrating with Ins(3,4)P2 prompted us to reexamine the levels of Ins(1, 3,4)P3 in middle T antigen-transformed cells. Ins (1,3,4) P3 is a known precursor of Ins(3,4)P2 (35) . By using a shallow gradient of ammonium formate-phosphate during HPLC elution, we obtained clear separation of the Ins(1,3,4)P3 and Ins(1,4,5)P3 isomers (Fig. 3) . We found significantly elevated levels of a compound which comigrated with Ins(1,3,4)P3 in cells transformed with wild-type middle T antigen (Table 6) . When extended to include the middle T antigen mutants, this analysis revealed increased levels of this compound in all cell lines which exhibited Ptdlns 3-kinase activity in vitro, although the low levels of radioactivity in this analysis prevented derivation of significance values. By contrast, no differences in Ins(1,4,5)P3 levels which correlated with either cell transformation or associated Ptdlns 3-kinase activity in vitro were found. We conclude that association of Ptdlns 3-kinase activity with middle T antigen appears to correlate with elevated Ins(1,3,4)P3, but not Ins(1,4,5)P3, levels.
DISCUSSION
Middle T antigen-transformed cells have elevated levels of PtdIns(3)P. Binding of middle T antigen to cellular tyrosine kinase pp60csrc and related kinases is an essential step in cell transformation by polyomavirus, yet little is known about the consequences of this interaction. Insight into this question may be gained by the finding of a third member of this complex, an 81-to 85-kilodalton protein whose presence correlates with Ptdlns 3-kinase activity. p81 is phosphorylated on tyrosine and therefore represents a likely substrate for pp60c-src kinase activity in vivo. In this study, the levels of Ptdlns(3)P were significantly elevated in cells expressing wild-type and certain mutant middle T antigens. We conclude, therefore, that association of Ptdlns 3-kinase activity with middle T antigen in vitro correlates with activation of Ptdlns 3-kinase activity in vivo.
Association of middle T antigen with activated pp6Ocsrc and related kinases is required, but not sufficient, for changes in the level of Ptdlns(3)P. Cell lines expressing d123 middle T antigen, for example, bind pp6Ocsrc and partially elevate its kinase activity but do not exhibit changes in cellular Ptdlns(3)P levels. Efficient binding of p81 and, hence, activation of PtdIns 3-kinase activity may be dependent upon the phosphorylation state of middle T antigen. Talmage et al. (42) have demonstrated that middle T antigen lacking the major site of tyrosine phosphorylation does not have associated Ptdlns 3-kinase activity. We note that this site is missing in d123 middle T antigen but present in another middle T antigen mutant (82JF3); both fail to bind p81 (8) .
PtdIns 3-kinase activity associated with the middle T antigen phosphorylates the D-3 position of the inositol ring to form Ptdlns(3)P (35, 43) and products with proposed Ptdlns(3,4)P2 and PtdIns(3,4,5)P3 structures (1) . We have extended these findings to show that PtdIns 3-kinase activity associated with both wild-type and mutant middle T antigens also recognizes PtdIns(4)P and Ptdlns(4,5)P2 substrates. Phosphorylation of these substrates was dependent upon the presence of Mg2+ and high ATP concentrations, whereas formation of PtdIns(3)P by Ptdlns 3-kinase was efficient at low ATP concentrations in the presence of Mn2+ (data not shown). The reason why the different substrates are phosphorylated under different reaction conditions is not clear.
The modest extent to which Ptdlns(3)P levels are elevated in middle T antigen-transformed cells is comparable to the level of PtdIns(3)P induced in cells after stimulation with PDGF, when Ptdlns 3-kinase is maximally activated (E.T.U., unpublished data). The level of Ptdlns(3)P was only marginally elevated in serum-starved middle T antigentransformed cells after PDGF treatment, yet the transformed cells could still respond to PDGF as measured by Li+-sensitive inositol phosphate accumulation (7) or immune precipitation of PtdIns 3-kinase activity with antiphosphotyrosine antibodies (E.T.U., unpublished data). This suggests that although the inositol-signalling pathway is intact in middle T antigen-transformed cells, there is a maximum level of PtdIns(3)P that accumulates in cells. Our data suggest that middle T antigen-transformed cells have attained this level. Ptdlns(4)P levels were significantly reduced in cells expressing activated Ptdlns 3-kinase. It is unclear why our data on PtdIns(4)P levels differ from those previously described. Kaplan et al. (21) reported a 50% increase in Ptdlns(4)P levels in polyomavirus-infected cells relative to those of mock-infected controls. Such a discrepancy may arise from differences in the lipid extraction protocol or from the use of virus-infected cells. We feel that the reduction in Ptdlns(4)P levels we observed is not a consequence of phospholipase C activation during extraction, because a concomitant increase in the levels of immediate phospholipase C products, e.g., Ins(1,4)P2, was not observed. One possibility is that reduced Ptdlns(4)P levels in cells which have activated PtdIns 3-kinase arise from a limitation in the availability of substrate Ptdlns to the kinase which produces PtdIns(4)P. By using a dual [3H]-and [14C]inositol-labeling procedure, Stephens et al. (39) demonstrated that turnover of the inositol moiety of Ptdlns(3)P was similar to that of Ptdlns(4)P, suggesting that these compounds arise from a common pool of Ptdlns. Alternatively, reduced PtdIns(4)P levels may arise from an effect on the other kinases, phosphatases, or phospholipases which maintain PtdIns(4)P and Ptdlns(4,5)P2 levels in equilibrium.
A further effect of middle T antigen expression on inositol lipid metabolism involves the appearance of elevated GroPIns levels in cells which express middle T antigens which associate with Ptdlns 3-kinase. Elevated GroPIns levels in these cells most likely arise from concerted phospholipase A2 and A1 activity on Ptdlns. These results will be presented elsewhere (E.T.U., unpublished data). The accumulation of novel compounds in middle T antigen-transformed cells might also arise from activation of distinct metabolic pathways. In this regard, it is noteworthy that cells transformed with pp6Ov-src exhibit elevated levels of a compound which comigrates with Ins(3,4,5,6)P4 (19) . We emphasize that our structural assignments for the InsP2 and InsP4 species are tentative and that these products might also evolve from pathways involving InsP5 and/or InsP6 intermediates, as suggested by Shears (35) . In this respect, it is of interest that we have preliminary evidence for elevated levels of InsP5 and InsP6 in middle T antigen-transformed cells (E.T.U., unpublished data).
Auger et al. (1) recently proposed that after PDGF treatment of quiescent cultures, elevated Ins(1,3,4)P3 and Ins(1,3,4,5)P4 levels might arise by phospholipase C catalysis of Ptdlns(3,4)P2 and Ptdlns(3,4,5)P3, respectively. However, no phospholipase C activity which utilizes these Ptdlns 3-kinase products as substrates has been described (26, 34) . It should be stressed that Ins(1,3,4)P3 and Ins(1,3,4,5)P4 can arise from Ptdlns(4,5)P2 through an Ins(1,4,5)P3 intermediate (35) . Furthermore, Fukami et al. (13) have demonstrated that entry into the S phase by v-src-transformed cells can be partially reversed by microinjection of a PtdInsP2-specific antibody, suggesting involvement of Ptdlns(4,5)P2 intermediate in this signaling pathway. It remains to be determined whether middle T antigen-associated PtdIns 3-kinase activates inositol-signaling pathways which are independent of a Ptdlns(4,5)P2 intermediate.
